IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0122795.html
   My bibliography  Save this article

Direct Medical Cost of Type 2 Diabetes in Singapore

Author

Listed:
  • Charmaine Shuyu Ng
  • Matthias Paul Han Sim Toh
  • Yu Ko
  • Joyce Yu-Chia Lee

Abstract

Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be $2,034, of which 61% was accounted for by inpatient services, 35% by outpatient services, and 4% by A&E services. Independent determinants of total costs were DM treatments such as the use of insulin only (p

Suggested Citation

  • Charmaine Shuyu Ng & Matthias Paul Han Sim Toh & Yu Ko & Joyce Yu-Chia Lee, 2015. "Direct Medical Cost of Type 2 Diabetes in Singapore," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-11, March.
    • Handle: RePEc:plo:pone00:0122795
    DOI: 10.1371/journal.pone.0122795
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122795
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0122795&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0122795?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Tarricone, Rosanna, 2006. "Cost-of-illness analysis: What room in health economics?," Health Policy, Elsevier, vol. 77(1), pages 51-63, June.
    2. Mehdi Javanbakht & Hamid R Baradaran & Atefeh Mashayekhi & Ali Akbar Haghdoost & Mohammad E Khamseh & Erfan Kharazmi & Aboozar Sadeghi, 2011. "Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-7, October.
    3. Betty Tao & Massimo Pietropaolo & Mark Atkinson & Desmond Schatz & David Taylor, 2010. "Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method," PLOS ONE, Public Library of Science, vol. 5(7), pages 1-11, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Xiao Zhang & Serena Low & Neelam Kumari & Jiexun Wang & Keven Ang & Darren Yeo & Chee Chew Yip & Subramaniam Tavintharan & Chee Fang Sum & Su Chi Lim, 2017. "Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore," PLOS ONE, Public Library of Science, vol. 12(7), pages 1-11, July.
    2. Ling Jie Cheng & Vivien Xi Wu & Susan Dawkes & Suan Tee Lim & Wenru Wang, 2019. "Factors influencing diet barriers among outpatients with poorly‐controlled type 2 diabetes: A descriptive correlational study," Nursing & Health Sciences, John Wiley & Sons, vol. 21(1), pages 102-111, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lan Gao & Hao Hu & Fei-Li Zhao & Shu-Chuen Li, 2016. "Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-17, January.
    2. Sanjib Saha & Ulf Gerdtham, 2013. "Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review," Health Economics Review, Springer, vol. 3(1), pages 1-12, December.
    3. Joanna M Charles & Deirdre M Harrington & Melanie J Davies & Charlotte L Edwardson & Trish Gorely & Danielle H Bodicoat & Kamlesh Khunti & Lauren B Sherar & Thomas Yates & Rhiannon Tudor Edwards, 2019. "Micro-costing and a cost-consequence analysis of the ‘Girls Active’ programme: A cluster randomised controlled trial," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-17, August.
    4. Chien-Yuan Sher & Ho Ting Wong & Yu-Chun Lin, 2020. "The Impact of Dengue on Economic Growth: The Case of Southern Taiwan," IJERPH, MDPI, vol. 17(3), pages 1-12, January.
    5. Hanna Gyllensten & Michael Wiberg & Kristina Alexanderson & Anders Norlund & Emilie Friberg & Jan Hillert & Olivia Ernstsson & Petter Tinghög, 2018. "Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(3), pages 435-446, April.
    6. Karine Chevreul & Coralie Gandré & Karen Berg Brigham & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schiep, 2016. "Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 43-52, April.
    7. Jamison Pike & Scott D. Grosse, 2018. "Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 765-778, December.
    8. Hazo, Jean-Baptiste & Gandré, Coralie & Leboyer, Marion & Obradors-Tarragó, Carla & Belli, Stefano & McDaid, David & Park, A-La & Maliandi, Maria Victoria & Wahlbeck, Kristian & Wykes, Til & van Os, J, 2017. "National funding for mental health research in Finland, France, Spain and the United Kingdom," LSE Research Online Documents on Economics 82339, London School of Economics and Political Science, LSE Library.
    9. Susanne Mayer & Jonah Spickschen & K Viktoria Stein & Richard Crevenna & Thomas E Dorner & Judit Simon, 2019. "The societal costs of chronic pain and its determinants: The case of Austria," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-18, March.
    10. Bugge, Christoffer & Sæther, Erik Magnus & Brustugun, Odd Terje & Kristiansen, Ivar Sønbø, 2021. "Societal cost of cancer in Norway –Results of taking a broader cost perspective," Health Policy, Elsevier, vol. 125(8), pages 1100-1107.
    11. Karine Chevreul & Morgane Michel & Karen Berg Brigham & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schiep, 2016. "Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 7-18, April.
    12. Paul Hanly & Rebecca Maguire & Frances Drummond & Linda Sharp, 2019. "Variation in the methodological approach to productivity cost valuation: the case of prostate cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1399-1408, December.
    13. Miley, Frances & Read, Andrew, 2021. "Soldiers don't go mad: Shell shock and accounting intransigence in the British Army 1914-18," The British Accounting Review, Elsevier, vol. 53(2).
    14. François-Olivier Baudot & Anne-Sophie Aguadé & Thomas Barnay & Christelle Gastaldi-Ménager & Anne Fagot-Campagna, 2019. "Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 657-668, July.
    15. Kalseth, Jorid & Halvorsen, Thomas & Kalseth, Birgitte & Sarheim Anthun, Kjartan & Peltola, Mikko & Kautiainen, Kirsi & Häkkinen, Unto & Medin, Emma & Lundgren, Jonatan & Rehnberg, Clas & Másdóttir, B, 2014. "Cross-country comparisons of health-care costs: The case of cancer treatment in the Nordic countries," Health Policy, Elsevier, vol. 115(2), pages 172-179.
    16. Allison Larg & John Moss, 2011. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 29(8), pages 653-671, August.
    17. Fernando Gracia & Mario Larreategui & Gaudencio Rodríguez & Aaron Benzadón & Michelle Ortiz & Divian Morales & Claudia Domínguez & Rosa Enith Carrillo & Carlos Valderrama & Luís Lizán & Blas Armién, 2018. "Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-12, October.
    18. Tien Thanh, Pham & Bao Duong, Pham, 2022. "The economic burden of non-communicable diseases on households and their coping mechanisms: Evidence from rural Vietnam," World Development, Elsevier, vol. 151(C).
    19. Foster, Nicola & Vassall, Anna & Cleary, Susan & Cunnama, Lucy & Churchyard, Gavin & Sinanovic, Edina, 2015. "The economic burden of TB diagnosis and treatment in South Africa," Social Science & Medicine, Elsevier, vol. 130(C), pages 42-50.
    20. Mehdi Javanbakht & Atefeh Mashayekhi & Hamid R Baradaran & AliAkbar Haghdoost & Ashkan Afshin, 2015. "Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-17, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0122795. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.